Gerald Nabozny

2.3k total citations
54 papers, 1.5k citations indexed

About

Gerald Nabozny is a scholar working on Immunology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gerald Nabozny has authored 54 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 15 papers in Genetics and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gerald Nabozny's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Estrogen and related hormone effects (12 papers) and Cell Adhesion Molecules Research (12 papers). Gerald Nabozny is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Estrogen and related hormone effects (12 papers) and Cell Adhesion Molecules Research (12 papers). Gerald Nabozny collaborates with scholars based in United States, France and Germany. Gerald Nabozny's co-authors include Chella S. David, Marie Griffiths, Cheng Shen, Harvinder S. Luthra, Mark Boothby, Ana L. Mora, Jin Chen, Dominic Cosgrove, Jeanine Baisch and H. S. Luthra and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Gerald Nabozny

54 papers receiving 1.5k citations

Peers

Gerald Nabozny
John M. Rumberger United States
Michael Furlong United States
Elzbieta Kawinski United States
Brian Bolognese United States
Wim H.A. Dokter Netherlands
Julia M. Ayala United States
Alan H. Davidson United Kingdom
Gerald Nabozny
Citations per year, relative to Gerald Nabozny Gerald Nabozny (= 1×) peers Shinzo Nishi

Countries citing papers authored by Gerald Nabozny

Since Specialization
Citations

This map shows the geographic impact of Gerald Nabozny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Nabozny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Nabozny more than expected).

Fields of papers citing papers by Gerald Nabozny

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Nabozny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Nabozny. The network helps show where Gerald Nabozny may publish in the future.

Co-authorship network of co-authors of Gerald Nabozny

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Nabozny. A scholar is included among the top collaborators of Gerald Nabozny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Nabozny. Gerald Nabozny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaufman, Julia, Gerald Nabozny, David L. Ebenezer, et al.. (2025). Avenciguat: a novel soluble guanylate cyclase activator that affects multiple cell types to inhibit IFN-1 signalling and fibrosis. Lara D. Veeken. 64(8). 4738–4743. 1 indexed citations
2.
Nabozny, Gerald, Émilie Dumas, Eveline Verheugen, et al.. (2024). Intestinal epithelial expression of human TNF is sufficient to induce small bowel inflammation and sacroiliitis, mimicking human spondyloarthritis. Lara D. Veeken. 64(5). 3116–3124. 1 indexed citations
3.
Venken, Koen, Tine Decruy, Ann‐Sophie De Craemer, et al.. (2023). Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis. Annals of the Rheumatic Diseases. 82(8). 1076–1090. 7 indexed citations
4.
Chalmers, Samantha A., Jing Wen, Jessica Doerner, et al.. (2018). Highly selective inhibition of Bruton’s tyrosine kinase attenuates skin and brain disease in murine lupus. Arthritis Research & Therapy. 20(1). 10–10. 38 indexed citations
5.
Kang, Kyuho, Sung Ho Park, Janice Chen, et al.. (2017). Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF. Immunity. 47(2). 235–250.e4. 133 indexed citations
6.
Razavi, Hossein, Doris Riether, Christian Harcken, et al.. (2014). Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore. Bioorganic & Medicinal Chemistry Letters. 24(8). 1934–1940. 7 indexed citations
7.
Kuzmich, Daniel, Jörg Bentzien, Raj Betageri, et al.. (2013). Function-regulating pharmacophores in a sulfonamide class of glucocorticoid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 23(24). 6640–6644. 6 indexed citations
8.
Kroe‐Barrett, Rachel, Neil A. Farrow, Jerry L. Hopkins, et al.. (2007). Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor. Biophysical Chemistry. 128(2-3). 156–164. 17 indexed citations
9.
Panzenbeck, M. J., Deborah D. Jeanfavre, Terence A. Kelly, et al.. (2006). An orally active, primate selective antagonist of LFA-1 inhibits delayed-type hypersensitivity in a humanized-mouse model. European Journal of Pharmacology. 534(1-3). 233–240. 8 indexed citations
10.
Betageri, Raj, Yan Zhang, Renée Zindell, et al.. (2005). Trifluoromethyl group as a pharmacophore: Effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand. Bioorganic & Medicinal Chemistry Letters. 15(21). 4761–4769. 89 indexed citations
11.
Drescher, Kristen M., Sarah Johnston, Gerald Nabozny, et al.. (2000). Vβ8+ T cells protect from demyelinating disease in a viral model of multiple sclerosis. International Immunology. 12(3). 271–280. 7 indexed citations
12.
Chapoval, Svetlana P., et al.. (1999). Short ragweed allergen induces eosinophilic lung disease in HLA-DQ transgenic mice. Journal of Clinical Investigation. 103(12). 1707–1717. 35 indexed citations
13.
Kelly, Terence A., Deborah D. Jeanfavre, Daniel W. McNeil, et al.. (1999). Cutting Edge: A Small Molecule Antagonist of LFA-1-Mediated Cell Adhesion. The Journal of Immunology. 163(10). 5173–5177. 109 indexed citations
14.
Fuller, Brian E., et al.. (1995). T‐Cell Receptor Vβ Gene Usage in Experimental Autoimmune Thyroiditisa. Annals of the New York Academy of Sciences. 756(1). 450–452. 6 indexed citations
15.
Nabozny, Gerald, Marie Griffiths, D.S. Harper, Harvinder S. Luthra, & Chella S. David. (1995). Identification of a Cyanogen Bromide Fragment of Porcine Type II Collagen Capable of Modulating Collagen Arthritis in B10.RIII (H-2r) Mice. Autoimmunity. 20(1). 39–49. 9 indexed citations
16.
González‐Gay, Miguel Á., Eric Zanelli, Christopher J. Krco, et al.. (1995). Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics. 42(1). 35–40. 38 indexed citations
17.
Nabozny, Gerald, Matthew Bull, J. A. Hanson, et al.. (1994). Collagen-induced arthritis in T cell receptor V beta congenic B10.Q mice.. The Journal of Experimental Medicine. 180(2). 517–524. 28 indexed citations
18.
González‐Gay, Miguel Á., Gerald Nabozny, Marilyn J. Bull, et al.. (1994). Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis.. The Journal of Experimental Medicine. 180(4). 1559–1564. 57 indexed citations
19.
Rodriguez, Moses, et al.. (1994). Influence of Deletion of T Cell Receptor VβGenes on the Theiler's Virus Model of Multiple Sclerosis. Autoimmunity. 19(4). 221–230. 9 indexed citations
20.
Nabozny, Gerald, et al.. (1990). Suppression in experimental autoimmune thyroiditis: The role of unique and shared determinants on mouse thyroglobulin in self-tolerance. Cellular Immunology. 131(1). 140–149. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026